End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.46 CNY | +2.96% |
|
+5.62% | -51.25% |
06-26 | Walvax Biotechnology Ends Vaccine Development Deal With Abogen Biotechnology | MT |
06-18 | Walvax Terminates Coronavirus Vaccine Trials Due to Mutations | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.25% | 2.45B | |
+7.46% | 100B | |
+11.97% | 42.34B | |
-12.29% | 32.76B | |
+79.34% | 29.46B | |
-12.45% | 16.31B | |
+2.69% | 14.39B | |
-1.90% | 12.23B | |
+178.17% | 10.47B | |
+1.80% | 8.97B |
- Stock Market
- Equities
- 300142 Stock
- News Walvax Biotechnology Co., Ltd.
- Walvax Biotechnology Buys Back 170,000 Shares; Stock Rises 3%